相关实验视频

Updated: May 5, 2026

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

两性多 (γ-胺酸) 衍生物用于在癌细胞中输送多克索鲁比

Porochista Dorost¹, Miguel R G Morais^2,3,4, Sofia Cunha Guimarães^2,3

¹Departament d´Enginyeria Química, Universitat Politècnica de Catalunya, ETSEIB, Barcelona, Spain.

Macromolecular bioscience

|June 22, 2025

概括

研究人员从聚-氨酸中开发了新的两性纳米粒子,用于增强癌症药物输送. 这些可生物降解的载体有效地将多克索鲁比辛输送到U-87质瘤细胞中,超过了免费药物输送的性能.

科学领域:

生物材料科学生物材料科学
纳米技术纳米技术
癌症治疗方法癌症治疗方法

背景情况:

有效地将抗癌药物输送到瘤部位仍然是癌症治疗中的一个重大挑战.
开发具有生物相容性和生物降解性的药物载体对于提高治疗疗效和减少副作用至关重要.

研究的目的:

为向癌症药物输送合成和特征化形多分子 (γ-胺酸) 纳米颗粒.
评估细胞吸收,药物释放动力学和开发的纳米颗粒的体外抗癌疗效.

主要方法:

两性多 (γ-胺酸) 被合成并通过纳米沉自组合成纳米粒子.
纳米颗粒的特征包括尺寸分析,用聚乙烯糖醇 (PEG) 和叶酸 (FA-PEG-NH2) 进行表面修饰,以及光谱确认 (1H-NMR,FTIR).
评估了细胞相容性,细胞吸收 (色素异硫酸标签),多克索鲁比辛加载,pH敏感药物释放,以及对U-87质瘤细胞的体外疗效.

主要成果:

合成的纳米粒子与U-87质瘤细胞具有良好的细胞相容性.
使用PEG和FA-PEG-NH2进行表面修饰,分别产生了174nm和156nm的纳米粒子.
多克索鲁比的释放依赖于pH值,在酸性pH值 (4.2) 的释放速度比生理pH值 (7.4) 快.
与自由多克索鲁比相比,封装多克索鲁比对U-87细胞的有效性显著提高.

结论:

基于聚-胺酸的纳米粒子是改善疏水抗癌药物的输送的有希望的载体.
开发的纳米粒子显示了通过向药物输送和改善治疗结果来增强癌症治疗的潜力.
对这些可生物降解的纳米载体的进一步研究可能会导致更有效的癌症疗法.

关键词:

质母细胞瘤细胞U-87 生物相容的聚合物.药物输送纳米颗粒纳米颗粒疏水性修饰是一种疏水性修饰.聚-γ-胺酸) 是一种聚-γ-胺酸.

更多相关视频

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...